Analysts Miffed By Vertex’s Lack Of Transparency With CF Combo Data
This article was originally published in The Pink Sheet Daily
Executive Summary
Vertex Pharmaceuticals presented top-line data for its drug combination in cystic fibrosis, but analysts are wondering why the company was not forthcoming about the full data set.